Michaela Levin
Vermögen: 61 500 $ am 30.09.2026
Vermögen: 61 500 $ am 30.09.2026
Michaela Levin is currently Chief Business Officer at Acrivon Therapeutics, Inc. Formerly, Dr. Levin was Vice President-Business Development at Recursion Pharmaceuticals, Inc. Dr. Levin earned a doctorate from the University of Virginia.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.08.2026 | 30 000 ( 0,07 % ) | 61 500 $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Corporate Officer/Principal | 31.08.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| RECURSION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 3 |
|---|---|
Recursion Pharmaceuticals, Inc.
Recursion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that combines biology, chemistry, automation, data science and engineering to industrialize drug discovery | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen